According to a new market research report, the cell therapy industry is expected to grow from $7.75 billion in 2019 to $48.11 billion by 2027, registering an impressive CAGR of 25.6% from 2020 to 2027. The market covers a broad spectrum of cell types including stem cells and non-stem cells, with therapy types spanning autologous and allogeneic approaches. Key therapeutic areas driving demand include malignancies, musculoskeletal disorders, autoimmune conditions, and dermatology, with hospitals, clinics, and academic research institutes serving as the primary end users. The rapidly evolving landscape of cell-based treatments is reshaping how chronic and life-threatening conditions are managed globally, making cell therapy one of the most promising and fast-moving segments in modern medicine.
Drivers, restraints, and opportunities –
Technological advancements in the medical field, rise in number of cell therapies in clinical studies, and increase in adoption of regenerative medicines fuel the growth of the market for global cell therapy. On the other hand, high costs of the therapy impede the growth to some extent. However, high growth potential in emerging markets is expected to pave the way for numerous opportunities for the key players in the sector.
Key Market Players –
- HOLOSTEM TERAPIE AVANZATE SRL,
- CELLS FOR CELLS,
- ALLOSOURCE,
- MEDIPOST CO., LTD.,
- STEMEDICA CELL TECHNOLOGIES, INC,
- MESOBLAST LTD,
- OSIRIS THERAPEUTICS, INC.,
- KOLON TISSUEGENE, INC.,
- NUVASIVE, INC.,
- JCR PHARMACEUTICALS CO., LTD.
Cell therapy is an integral part of immunotherapy that has shown excellent therapeutic ability in several clinical indications. In recent years, studies regarding the use of cells for their therapeutic ability have gained immense popularity in scientific and healthcare research communities. In addition, several techniques such as CAR-T cell therapy, stem cell therapy, and cord blood cell therapy have gained extreme popularity, owing to their wide applications in several clinical indications such as cancer and cardiovascular disease.
Cell therapy is a technology, which relies on replacing diseased or dysfunctional cells with healthy functioning ones. Cells mainly used for such advanced therapies are stem cells, owing to their ability to differentiate into specific cells required for repairing damaged or defective tissues or cells. Moreover, cell therapy finds its application in development of regenerative medicines, which is a multidisciplinary area aimed at maintenance, improvement, or restoration of cells, tissues, or organ functioning, using methods mainly related to cell therapy.
★ See What’s Inside This Report @
https://www.alliedmarketresearch.com/purchase-enquiry/5330
Almost every nation is dealing with the outbreak. Most markets are dropping down, owing to the outbreak, including the cell therapy market. The cell therapy market is negatively impacted by the pandemic as most countries adopted lockdown to combat the pandemic. In addition, most of the clinics across the globe have stopped undertaking new cases of stem cell therapy, organ transplant and other treatment for next few months, till the condition seems to be under control.
Development of cell banking facilities, coupled with expansion of production, characterization, and storage of cells have improved volumetric capabilities of the cell therapy market. This has further resulted in increase in revenue generation for non-stem and stem cell therapies across the globe. High adoption of regenerative medicine along with the advent of novel technologies and platforms boost the market growth.
Based on cell type, the stem cell segment contributed to nearly three-fifths of the global cell therapy market share in 2019 and is expected to retain its dominance by 2027. The same segment would also grow at the fastest CAGR of 26.1% throughout the forecast period. Increase in awareness regarding storage of stem cells have a positive effect on the market. Also, the number of stem cell banks is increasing in the developing nations. These factors fuel the growth of the segment.
However, certain pharmacological and manufacturing issues and regulatory hurdles hamper demand for cell therapy and restrain growth of the target market. On the contrary, increase in adoption of cell therapy technologies in developing countries is expected to create a lucrative opportunity for growth of the global cell therapy market.
About Us
Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides end-to-end solutions along with information, education, advocacy, and networking resources to SMEs and early-stage start-ups to bring excellence to their processes. In addition, we offer a nurturing environment required to develop and grow businesses, including business planning; virtual support; market intelligence; acquiring resources; and getting direct access to finance, suppliers, and other experts to boost the growth of businesses and entrepreneurs.
Our bundled and hassle-free business support systems are customized to meet the needs of SME consultants and industry leaders. Moreover, our large network of skilled consultants and experts help start-ups get the business on a roll.
Contact:
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int’l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
[email protected]
